Stredrick Denise L, Stokes Alan H, Worst Travis J, Freeman Willard M, Johnson Elizabeth A, Lash Lawrence H, Aschner Michael, Vrana Kent E
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA.
Neurotoxicology. 2004 Jun;25(4):543-53. doi: 10.1016/j.neuro.2003.08.006.
Manganese (Mn) is an essential metal that, at excessive levels in the brain, produces extrapyramidal symptoms similar to those in patients with Parkinson's disease (PD). In the present study, Mn toxicity was characterized in a human neuroblastoma (SK-N-SH) cell line and in a mouse catecholaminergic (CATH.a) cell line. Mn was demonstrated to be more toxic in the catecholamine-producing CATH.a cells (EC50 = 60 microM) than in non-catecholaminergic SK-N-SH cells (EC50 = 200 microM). To test the hypothesis that the sensitivity of CATH.a cells to Mn is associated with their dopamine (DA) content, DA concentrations were suppressed in these cells by pretreatment with alpha-methyl-para-tyrosine (AMPT). Treatment for 24 h with 100 microM AMPT decreased intracellular DA, but offered no significant protection from Mn exposure (EC50 = 60 microM). Additional studies were carried out to assess if Mn toxicity was dependent on glutathione (GSH) levels. CATH.a cells were significantly protected by the addition of 5mM GSH (Mn EC50 = 200 microM) and 10mM N-acetyl cysteine (NAC) (Mn EC50 = 300 microM), therefore, indirectly identifying intracellular ROS formation as a mechanism for Mn neurotoxicity. Finally, apoptotic markers of Mn-induced cell death were investigated. DNA fragmentation, caspase-3 activation, and apoptosis-related gene expression were studied in CATH.a cells. No internucleosomal fragmentation or caspase activation was evident, even in the presence of "supraphysiological" Mn concentrations. cDNA hydridization array analysis with two differing Mn concentrations and time points, identified no noteworthy mRNA inductions of genes associated with programmed cell death. In conclusion, DA content was not responsible for the enhanced sensitivity of CATH.a cells to Mn toxicity, but oxidative stress was implicated as a probable mechanism of cytotoxicity.
锰(Mn)是一种必需金属,在大脑中含量过高时,会产生与帕金森病(PD)患者相似的锥体外系症状。在本研究中,在人神经母细胞瘤(SK-N-SH)细胞系和小鼠儿茶酚胺能(CATH.a)细胞系中对锰毒性进行了表征。结果表明,锰在产生儿茶酚胺的CATH.a细胞(半数有效浓度[EC50]=60微摩尔)中比在非儿茶酚胺能SK-N-SH细胞(EC50=200微摩尔)中更具毒性。为了验证CATH.a细胞对锰的敏感性与其多巴胺(DA)含量相关这一假设,通过用α-甲基-对-酪氨酸(AMPT)预处理来抑制这些细胞中的DA浓度。用100微摩尔AMPT处理24小时可降低细胞内DA,但对锰暴露没有显著保护作用(EC50=60微摩尔)。还进行了其他研究以评估锰毒性是否依赖于谷胱甘肽(GSH)水平。添加5毫摩尔GSH(锰EC50=200微摩尔)和10毫摩尔N-乙酰半胱氨酸(NAC)(锰EC50=300微摩尔)可显著保护CATH.a细胞,因此,间接确定细胞内活性氧形成是锰神经毒性的一种机制。最后,研究了锰诱导细胞死亡的凋亡标志物。在CATH.a细胞中研究了DNA片段化、半胱天冬酶-3激活和凋亡相关基因表达。即使在存在“超生理”锰浓度的情况下,也没有明显的核小体间片段化或半胱天冬酶激活。用两种不同的锰浓度和时间点进行cDNA杂交阵列分析,未发现与程序性细胞死亡相关基因有值得注意的mRNA诱导。总之,DA含量不是CATH.a细胞对锰毒性敏感性增强的原因,但氧化应激可能是细胞毒性的一种机制。